Patents by Inventor Boris Klementiev

Boris Klementiev has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptides derived from NCAM (FGLs)
    Patent number: 8470964
    Abstract: The present invention relates to novel compounds comprising at most 13 contiguous amino acid residues derived from the fibronectin type 3,11 module of neural cell adhesion molecule (NCAM), or a variant or fragment thereof, capable of interacting with an FGFR and thereby the compounds are capable of inducing differentiation, modulating proliferation, stimulate regeneration, neuronal plasticity or survival of cells. Further, the present invention relates to the use of the compounds for production of a medicament for treatment of conditions and diseases, in which NCAM or FGFR play a prominent role.
    Type: Grant
    Filed: November 28, 2008
    Date of Patent: June 25, 2013
    Assignee: Enkam Pharmaceuticals A/S
    Inventors: Vladimir Berezin, Elisabeth Bock, Soren Ebdrup, Boris Klementiev
  • NOVEL PEPTIDES DERIVED FROM NCAM (FGLs)
    Publication number: 20110098225
    Abstract: The present invention relates to novel compounds comprising at most 13 contiguous amino acid residues derived from the fibronectin type 3,I1 module of neural cell adhesion molecule (NCAM), or a variant or fragment thereof, capable of interacting with an FGFR and thereby the compounds are capable of inducing differentiation, modulating proliferation, stimulate regeneration, neuronal plasticity and/or survival of cells. Further, the present invention relates to the use of said compounds for production of a medicament for treatment of conditions and diseases, wherein NCAM and/or FGFR play a prominent role.
    Type: Application
    Filed: November 28, 2008
    Publication date: April 28, 2011
    Inventors: Vladimir Berezin, Elisabeth Bock, Søren Ebdrup, Boris Klementiev